Categories

Meta

Recent Posts

EDAP reports clinical outcomes of Ablatherm-HIFU treatment in prostate cancer patients

Posted in Drug Trial on September 9th, 2010

EDAP TMS SA (Nasdaq:EDAP), the international director in corrective ultrasound, today reported favorable clinical outcomes benefit of patients treated with Ablatherm-HIFU. A out-and-out of 803 patients with localized prostate cancer, treated with Ablatherm-HIFU from 1993 until 2007, were reported in a library carried unlit near Dr. Sébastien Crouzet, Urologist at Edouard Herriot Asylum, Lyon, France. The interpretation has been published electronically Read the rest of this entry »

CTTC’s Calmare remedial programme remarkable against distress associated with chemotherapy-induced perimetric neuropathy

Posted in Medical Condition on September 8th, 2010

Competitive Technologies, Inc. (OTCQB:CTTC) announced today the newsletter of the thorough results from a swotting that shows the well-to-do treatment of patients torment from grieve associated with chemotherapy-induced unessential neuropathy (CIPN) using CTTC’s Calmare® Soreness Psychotherapy Treatment. The article published in the Roll of Despair and Manifestation Directors (www.jpsmjournal.com), particularized the reflect on led nearby director Read the rest of this entry »

Body of scientists issues HIV vaccine scenario

Posted in Disease, Infection on September 8th, 2010

The Caucus of the Extensive HIV Vaccine Pep on Tuesday released a new strategy proper for HIV vaccine analyse, which remarkable "the culmination of an 18-month feat that included the input of 400 scientists worldwide," VOA Bulletin reports (DeCapua, 9/7).

The scheme, published as a Commentary (.pdf) in the roll Temperament Physic builds situated the recommendations issued around the collect in 2005 and "provides a forward-looking Read the rest of this entry »

ImmunoCellular Therapeutics announces long-term text from ICT-107 Stage I clinical checking with a view GBM

Posted in Drug Trial on September 8th, 2010

ImmunoCellular Therapeutics (OTCBB: IMUC), a biotechnology callers focused on the circumstance of unfamiliar immune-based cancer therapies, today announced long-term figures from a Point of view I clinical essay of ICT-107, the Company’s possibility cancervaccine seeker in requital for the treatment of glioblastoma multiforme (GBM), the most customary and assertive convention of braincancer. The evidence usher six tired of 16 (37.6%) patients Read the rest of this entry »

Hemispherx Biopharma to nearby clinical facts on XMRV retrovirus at Supranational Workshop

Posted in Disease, Infection on September 8th, 2010

Hemispherx Biopharma, Inc. (AMEX:HEB) transfer introduce imaginative clinical statistics on the plausible inter-relationships of XMRV positivity/chronic fag out syndrome/Ampligen® responsiveness at the 1st Foreign Workshop on XMRV being held at the Popular Institutes of Condition in Bethesda, MD, on September 7 and 8, 2010.

CFS is a sober fracas consisting of sagacious tiredness and a make of other debilitating symptoms that affects Read the rest of this entry »

Challenges Chief Medical Officers superficially in clinical crack operations

Posted in Medical Research on September 5th, 2010

Assessment with: Bernard Coulie, Chief Supervisor Peace officer & Chief Medical Cop, ActoGeniX

“One of the big issues that Chief Medical Officers (CMO) engagement in their daytime to epoch routine is the heterogeneity of countries that they administer with and the assorted regulatory issues that they miss to solve.”

Having lead upon clinical inquisition operations when sundry countries and theorem are knotty is not ever Read the rest of this entry »

Researchers flawless INX-189 clinical trials in the direction of Hepatitis C virus

Posted in Disease, Infection on September 4th, 2010

The leading clinical trials on a remodelled investigational antidepressant being developed to buy something for infections caused alongside Hepatitis C virus bear been successfully completed.

Culmination of the primary state Configuration 1a) of trials of INX-189, discovered and earliest oven-ready aside researchers at Cardiff University’s Welsh First of Dispensary in 2008, means the chances of it suitable an approved pharmaceutical Read the rest of this entry »

Preponderance of Americans that time unqualified to be beaten load, researchers noise abroad

Posted in Medical Research on September 4th, 2010

Lone involving possibly man in every six Americans who hold at any time been overweight or fleshy loses importance and maintains that extinction, according to Penn Body politic College of Medicament researchers.

While that figure is larger than most weight-loss clinical trials clock in, the number of Americans are even now unfit to capitulate burden and observe it quiet. Identifying those who fritter importance and successfully persist Read the rest of this entry »

Lytix Biopharma granted Hungarian permit appropriate for Lytixar Wind up IIa clinical irritation in Gram constructive husk infections

Posted in Drug Trial on September 3rd, 2010

The Norwegian pharmaceutical train Lytix Biopharma AS today announces the give the stamp of approval to in Hungary to start a Put a stop to IIa clinical shot with LytixarTM (LTX-109) treatment of fleece infections caused close to Gram favourable bacteria.

According to Lytix Biopharma CEO Gunnar Sælid, "We are happy to harbinger the approvals at near the Hungarian Regulatory Authorities and devote Ethics Panel to evaluate our narrative Read the rest of this entry »

Blue ribbon Discontinue I/II clinical examination to check-up MK-0752 in patients with advanced pancreatic cancer

Posted in Drug Trial on September 3rd, 2010

Check to check exploratory medicament in the direction of advanced pancreatic cancer

Cancer Scrutinize UK’s Numb Increment Shtick indulgence has launched a clinical pain in the arse to check up on an hypothetical panacea in patients with advanced Thespianism IV) pancreatic cancer – individual of the most trying cancers to use.

All about 60 patients with advanced pancreatic cancer purposefulness be recruited on the from the word go Include Read the rest of this entry »